《新股消息》微創機器人(02252.HK)今日起招股 入場費21,817.66元
自微創醫療(00853.HK)分拆並擬於主板上市的微創機器人(02252.HK)公布,於全球發售3,620萬股H股,本港公開發售部份佔10%,招股價介乎36元至43.2元,每手500股,入場費21,817.66元。由今日起招股,下周二(26日)截止,預期同日定價,11月2日掛牌上市。聯席保薦人、聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人為摩根大通及中金公司,聯席牽頭經辦人為富途證券及利弗莫爾證券。
公司簽訂基石投資者協議,合共認購9,500萬美元等值股份,其中私募投資基金Aspex認購2,000萬美元,Hillhouse Funds、亞洲生命科學投資公司LAV、由雪湖資本擔任投資經理的Snow Lake Funds and Accounts及全球瘧疾控制項目公司Yorkool分別認購1,500萬美元,CloudAlpha認購1,000萬美元,Artisan認購500萬美元。
以招股價中位數39.6元計,公司料集資淨額13.32億元,其中35%用於其核心產品圖邁,21%用於其骨科手術機器人,19%用於其他候選產品,5%用於提高製造與供應鏈管理能力,10%用於通過向手術機器人行業及相關領域的公司及研究機構引進授權、收購該等公司及機構,其餘10%用作營運資金及一般公司用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.